This brand new DIA training course is entirely dedicated to Drug-Induced Liver Injury (DILI) and led by a Hepatologist with extensive experience in clinical assessment of DILI, who published ‘RUCAM’ the widely used causality assessment method of DILI. The course will cover the progress that has been made in the clinical detection and prevention of DILI in clinical trials and in postmarketing phase. New regulatory guidelines and their application need to be understood for an optimal assessment of DILI cases. Better use of typical tools is emphasised in order to improve patient safety and drug monitoring during new drug development, especially in large populations. This course will provide tools, explanations, examples and exercises for a better understanding of DILI and how best to apply that knowledge in day to day work.
The medical approach presented in this training course is also based on the conclusions of international consensus meetings on adverse drug reactions and guidelines published by regulatory authorities